Pathogens and autoantibodies

Pathogens and autoantibodies are broad categories of biological entities central to the fields of infectious disease and immunology, rather than specific molecular targets. Pathogens, including bacteria, viruses, fungi, and parasites, are external agents that invade the host and cause disease through mechanisms such as toxin production or direct cellular damage (Source: NIH, 2023). Autoantibodies are endogenous immunoglobulins produced by the host's immune system that erroneously target self-antigens, leading to chronic inflammation and tissue destruction in conditions like systemic lupus erythematosus or rheumatoid arthritis (Source: StatPearls, 2023). While not a single receptor or enzyme, these entities are the focus of diverse therapeutic strategies: anti-infectives target specific microbial components to eliminate pathogens, while immunomodulators like Rituximab or IVIG are used to deplete autoantibody-producing cells or neutralize circulating self-reactive proteins (Source: PubMed, 2022; Mayo Clinic, 2023). The interplay between these two is a significant area of research, as certain infections are known to trigger the production of autoantibodies through mechanisms like molecular mimicry (Source: Nature Reviews Rheumatology, 2021). Because this term encompasses thousands of distinct organisms and proteins, it is classified as a general category rather than a specific therapeutic target.

Other names

Infectious agentsSelf-reactive antibodiesMicrobial pathogensAuto-reactive immunoglobulins

Therapeutic mechanisms vary widely and include the direct neutralization of pathogens, inhibition of microbial replication (e.g., cell wall or protein synthesis inhibition), depletion of B-cells to reduce autoantibody production, and competitive inhibition of autoantibody binding to self-antigens.